Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhongzhen Guan

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2013
Reply to F. AdesZhongzhen Guan
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|January 20, 2011
[Expression of fas and P53 protein in resected non-small cell lung cancer and its prognostic significance]Wei Wang, Huiqiang Huang, Zhongzhen Guan
BMC Cancer|April 17, 2008
Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticlesSu Li, Anxun Wang, Wenqi Jiang, et al.
Asia-Pacific Journal of Clinical Oncology|December 1, 2010
A phase II study of gemcitabine plus paclitaxel in patients with metastatic breast cancer and prior anthracycline treatmentBinghe Xu, Zhenzhou Shen, Zefei Jiang, et al.
Medical Oncology (Northwood, London, England)|September 17, 2010
The sequence of drug administration influences the antitumor effects of bevacizumab and cyclophosphamide in a neuroblastoma modelZijun Zhen, Xiaofei Sun, Youjian He, et al.
Asia-Pacific Journal of Clinical Oncology|January 27, 2018
Capecitabine/cisplatin versus 5-fluorouracil/cisplatin in Chinese patients with advanced and metastatic gastric cancer: Re-analysis of efficacy and safety data from the ML17032 phase III clinical trialJia Chen, Jianping Xiong, Jiejun Wang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|April 30, 2002
[Capecitabine (xeloda) in the treatment of relapsed and metastatic breast cancer]Xiaoqing Liu, Santai Song, Zhongzhen Guan, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|December 4, 2010
[Predictive factors of gefitinib response and survival in Chinese patients with local advanced or metastatic non-small cell lung cancer]Lishan Lin, Li Zhang, Hongyun Zhao, et al.
Japanese Journal of Clinical Oncology|August 10, 2010
Clinical analysis of thymic regrowth following chemotherapy in children and adolescents with malignant lymphomaZijun Zhen, Xiaofei Sun, Yi Xia, et al.
International Journal of Hematology|December 25, 2009
Long-term results of pirarubicin versus doxorubicin in combination chemotherapy for aggressive non-Hodgkin's lymphoma: single center, 15-year experienceLinzhu Zhai, Chengcheng Guo, Yabing Cao, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2013
Reply to F. AdesZhongzhen Guan
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|January 20, 2011
[Expression of fas and P53 protein in resected non-small cell lung cancer and its prognostic significance]Wei Wang, Huiqiang Huang, Zhongzhen Guan
BMC Cancer|April 17, 2008
Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticlesSu Li, Anxun Wang, Wenqi Jiang, et al.
Asia-Pacific Journal of Clinical Oncology|December 1, 2010
A phase II study of gemcitabine plus paclitaxel in patients with metastatic breast cancer and prior anthracycline treatmentBinghe Xu, Zhenzhou Shen, Zefei Jiang, et al.
Medical Oncology (Northwood, London, England)|September 17, 2010
The sequence of drug administration influences the antitumor effects of bevacizumab and cyclophosphamide in a neuroblastoma modelZijun Zhen, Xiaofei Sun, Youjian He, et al.
Asia-Pacific Journal of Clinical Oncology|January 27, 2018
Capecitabine/cisplatin versus 5-fluorouracil/cisplatin in Chinese patients with advanced and metastatic gastric cancer: Re-analysis of efficacy and safety data from the ML17032 phase III clinical trialJia Chen, Jianping Xiong, Jiejun Wang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|April 30, 2002
[Capecitabine (xeloda) in the treatment of relapsed and metastatic breast cancer]Xiaoqing Liu, Santai Song, Zhongzhen Guan, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|December 4, 2010
[Predictive factors of gefitinib response and survival in Chinese patients with local advanced or metastatic non-small cell lung cancer]Lishan Lin, Li Zhang, Hongyun Zhao, et al.
Japanese Journal of Clinical Oncology|August 10, 2010
Clinical analysis of thymic regrowth following chemotherapy in children and adolescents with malignant lymphomaZijun Zhen, Xiaofei Sun, Yi Xia, et al.
International Journal of Hematology|December 25, 2009
Long-term results of pirarubicin versus doxorubicin in combination chemotherapy for aggressive non-Hodgkin's lymphoma: single center, 15-year experienceLinzhu Zhai, Chengcheng Guo, Yabing Cao, et al.
Pageof 3